George Miller Biography and Net Worth



George Lloyd Miller J.D. serves as Senior Vice President, General Counsel, Corporate Secretary of the Company. Previously, he served as Senior Vice President, General Counsel and Corporate Secretary for Sigma-Aldrich Corporation from 2009 to 2015. Prior to working at Sigma-Aldrich, he held senior legal positions with Novartis AG, a global healthcare company.

What is George Lloyd Miller's net worth?

The estimated net worth of George Lloyd Miller is at least $6.24 million as of November 6th, 2020. Mr. Miller owns 16,540 shares of West Pharmaceutical Services stock worth more than $6,241,369 as of April 19th. This net worth estimate does not reflect any other investments that Mr. Miller may own. Learn More about George Lloyd Miller's net worth.

How do I contact George Lloyd Miller?

The corporate mailing address for Mr. Miller and other West Pharmaceutical Services executives is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. West Pharmaceutical Services can also be reached via phone at (610) 594-2900 and via email at [email protected]. Learn More on George Lloyd Miller's contact information.

Has George Lloyd Miller been buying or selling shares of West Pharmaceutical Services?

George Lloyd Miller has not been actively trading shares of West Pharmaceutical Services over the course of the past ninety days. Most recently, George Lloyd Miller sold 9,000 shares of the business's stock in a transaction on Friday, November 6th. The shares were sold at an average price of $296.67, for a transaction totalling $2,670,030.00. Following the completion of the sale, the vice president now directly owns 16,540 shares of the company's stock, valued at $4,906,921.80. Learn More on George Lloyd Miller's trading history.

Who are West Pharmaceutical Services' active insiders?

West Pharmaceutical Services' insider roster includes Silji Abraham (Insider), Bernard Birkett (SVP), Annette Favorite (VP), Eric Green (CEO), Thomas Hofmann (Director), Quintin Lai (VP), George Miller (VP), Cindy Reiss-Clark (Insider), Chad Winters (CAO), and Patrick Zenner (Director). Learn More on West Pharmaceutical Services' active insiders.

Are insiders buying or selling shares of West Pharmaceutical Services?

In the last twelve months, insiders at the medical instruments supplier sold shares 17 times. They sold a total of 202,177 shares worth more than $74,559,298.70. The most recent insider tranaction occured on March, 11th when CAO Chad Winters sold 815 shares worth more than $292,438.30. Insiders at West Pharmaceutical Services own 0.5% of the company. Learn More about insider trades at West Pharmaceutical Services.

Information on this page was last updated on 3/11/2024.

George Lloyd Miller Insider Trading History at West Pharmaceutical Services

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/6/2020Sell9,000$296.67$2,670,030.0016,540View SEC Filing Icon  
5/1/2020Sell1,805$189.38$341,830.907,540View SEC Filing Icon  
See Full Table

George Lloyd Miller Buying and Selling Activity at West Pharmaceutical Services

This chart shows George Lloyd Miller's buying and selling at West Pharmaceutical Services by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

West Pharmaceutical Services Company Overview

West Pharmaceutical Services logo
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
Read More

Today's Range

Now: $377.35
Low: $372.41
High: $380.63

50 Day Range

MA: $379.31
Low: $350.18
High: $409.64

2 Week Range

Now: $377.35
Low: $310.42
High: $415.73

Volume

315,059 shs

Average Volume

315,021 shs

Market Capitalization

$27.63 billion

P/E Ratio

47.89

Dividend Yield

0.21%

Beta

1.04